CIK 0001689548 · Large accelerated filer
Praxis Precision Medicines, Inc.
Sign in to watch- Ticker
- PRAX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-300-8460
- Business address
- 99 HIGH STREET, 30TH FLOOR, BOSTON, MA, 02110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-07 | Nemiroff Alex General Counsel and Secretary | Shares withheld for taxes | −89 | $77.52 | $7K | 10,211.67 |
| 2025-01-07 | Kelly Timothy Edwin Chief Financial Officer | Shares withheld for taxes | −139 | $77.52 | $11K | 12,206 |
| 2024-11-14 | Mastrocola Lauren Principal Accounting Officer | Grant or award | +294 | $37.40 | $11K | 5,906.66 |
| 2024-11-14 | Kelly Timothy Edwin Chief Financial Officer | Grant or award | +205 | $37.40 | $8K | 12,345 |
| 2024-11-14 | Nemiroff Alex General Counsel and Secretary | Option exercise | +7,583 | $56.94 | $432K | 18,540 |
| 2024-11-14 | Nemiroff Alex General Counsel and Secretary | Sale | −8,239.33 | $80.20 | $661K | 10,300.67 |
| 2024-11-14 | Nemiroff Alex General Counsel and Secretary | Option exercise · Stock Option (Right to Buy) | −7,583 | 28,817 | ||
| 2024-11-14 | Mastrocola Lauren Principal Accounting Officer | Option exercise | +4,374 | $56.94 | $249K | 10,801 |
| 2024-11-14 | Mastrocola Lauren Principal Accounting Officer | Sale | −5,188.34 | $81.78 | $424K | 5,612.66 |
| 2024-11-14 | Mastrocola Lauren Principal Accounting Officer | Option exercise · Stock Option (Right to Buy) | −4,374 | 16,626 | ||
| 2024-07-29 | Souza Marcio Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +185,000 | 185,000 | ||
| 2024-07-29 | Nemiroff Alex General Counsel and Secretary | Grant or award | +7,800 | 10,957 | ||
| 2024-07-29 | Nemiroff Alex General Counsel and Secretary | Grant or award · Stock Option (Right to Buy) | +36,400 | 36,400 | ||
| 2024-07-29 | Mastrocola Lauren Principal Accounting Officer | Grant or award | +4,500 | 6,427 | ||
| 2024-07-29 | Mastrocola Lauren Principal Accounting Officer | Grant or award · Stock Option (Right to Buy) | +21,000 | 21,000 | ||
| 2024-07-29 | Kelly Timothy Edwin Chief Financial Officer | Grant or award | +7,800 | 12,140 | ||
| 2024-07-29 | Kelly Timothy Edwin Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +36,400 | 36,400 | ||
| 2024-06-05 | DeSimone Jill Director | Grant or award · Stock Option (Right to Buy) | +8,566 | 8,566 | ||
| 2024-06-05 | MITCHELL DEAN J Director | Grant or award · Stock Option (Right to Buy) | +8,566 | 8,566 | ||
| 2024-06-05 | Chodakewitz Jeffrey Director | Grant or award · Stock Option (Right to Buy) | +8,566 | 8,566 |
Page 8 of 17 · 331 trades